The University of Warwick Library - WebBridge

Will the US$5 million onasemnogene abeparvosec treatment for spinal muscular atrophy represent ‘value for money’ for the NHS? A rapid inquiry into suggestions that it may be cost-effective
Connock, Martin.  Expert Opinion on Biological Therapy.    2020. .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.